{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T21:10:16Z","timestamp":1764364216195},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ513","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:33:10Z","timestamp":1447115590000},"page":"S578-S585","source":"Crossref","is-referenced-by-count":10,"title":["Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali"],"prefix":"10.1093","volume":"61","author":[{"given":"Nicole E.","family":"Basta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoulaye","family":"Berthe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Onwuchekwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awa Traor\u00e9 Eps","family":"Demb\u00e9l\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Almond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Frankland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Manigart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline L.","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samba O.","family":"Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key\n\t\t\t\t20171013235115_CIV513C1","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20171013235115_CIV513C2","doi-asserted-by":"crossref","first-page":"20120147","DOI":"10.1098\/rstb.2012.0147","article-title":"The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?","volume":"368","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20171013235115_CIV513C3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20171013235115_CIV513C4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (MenAfriVac\u00ae) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013235115_CIV513C5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4161\/hv.19619","article-title":"Development of a group A meningococcal conjugate vaccine, MenAfriVac","volume":"8","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20171013235115_CIV513C6","article-title":"Summary of WHO position papers\u2014recommendations for routine immunization","author":"World Health Organization."},{"key":"key\n\t\t\t\t20171013235115_CIV513C7","article-title":"2014 assessment report of the Global Vaccine Action Plan","author":"Strategic Advisory Group of Experts on Immunization"},{"key":"key\n\t\t\t\t20171013235115_CIV513C8","first-page":"858","article-title":"Global routine vaccination coverage\u20142012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013235115_CIV513C9","first-page":"198","article-title":"Tetanus vaccine. Releve epidemiologique hebdomadaire\/Section d'hygiene du Secretariat de la Societe des Nations","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013235115_CIV513C10","article-title":"Immunization, vaccines, and biologicals. Data, statistics, and graphics","author":"World Health Organization."},{"key":"key\n\t\t\t\t20171013235115_CIV513C11","article-title":"Mali: WHO and UNICEF estimates of immunization coverage: 2013 revision","author":"World Health Organization."},{"key":"key\n\t\t\t\t20171013235115_CIV513C12","first-page":"e151","article-title":"Elimination of maternal and neonatal tetanus: a 21st-century challenge","volume":"5","year":"2012","journal-title":"Rev Obstet Gynecol"},{"key":"key\n\t\t\t\t20171013235115_CIV513C13","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013235115_CIV513C14","article-title":"Elimination of maternal and neonatal tetanus","author":"United Nation's Children's Fund"},{"key":"key\n\t\t\t\t20171013235115_CIV513C15","article-title":"Global Vaccine Action Plan monitoring, evaluation, and accountabilty","author":"World Health Organization Secretariat Annual Report"},{"key":"key\n\t\t\t\t20171013235115_CIV513C16","article-title":"Programme elargi de vaccination. Evaluation de la campagne de vaccination contre la meningite avec le vaccine MenAfriVac 2eme phase, dans les regions de Koulikoro, Segou et le district de Bamako au Mali en 2010","author":"Organisation mondiale de la sant\u00e9","year":"2011"},{"key":"key\n\t\t\t\t20171013235115_CIV513C17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/tmi.12125","article-title":"Meningococcal carriage in the African meningitis belt","volume":"18","author":"MenAfriCar Carriage Consortium","year":"2013","journal-title":"Trop Med Int Health"},{"issue":"(suppl 5)","key":"key\n\t\t\t\t20171013235115_CIV513C18","first-page":"S547","article-title":"Population-level persistence of immunity 2 years after the PsA-TT mass-vaccination campaign in Mali","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013235115_CIV513C19","first-page":"872","article-title":"Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae type b","volume":"9","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20171013235115_CIV513C20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(86)90176-4","article-title":"Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions","volume":"156","year":"1986","journal-title":"Anal Biochem"},{"key":"key\n\t\t\t\t20171013235115_CIV513C21","article-title":"Module 3: tetanus update 2006","year":"2007"},{"issue":"(suppl 5)","key":"key\n\t\t\t\t20171013235115_CIV513C22","first-page":"S570","article-title":"MenAfriVac as an antitetanus vaccine","volume":"61","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S578\/20914110\/civ513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T03:51:22Z","timestamp":1507953082000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S578\/418019\/Higher-Tetanus-Toxoid-Immunity-2-Years-After-PsATT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":22,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ513","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}